{"id":"https://openalex.org/W4391027296","doi":"https://doi.org/10.1002/iid3.1159","title":"Single ChAdOx1 nCoV\u201019 dose elicits stronger immune response in previously infected individuals than in SARS\u2010CoV2 naive persons","display_name":"Single ChAdOx1 nCoV\u201019 dose elicits stronger immune response in previously infected individuals than in SARS\u2010CoV2 naive persons","publication_year":2024,"publication_date":"2024-01-01","ids":{"openalex":"https://openalex.org/W4391027296","doi":"https://doi.org/10.1002/iid3.1159","pmid":"https://pubmed.ncbi.nlm.nih.gov/38270312","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10797648"},"language":"en","primary_location":{"id":"doi:10.1002/iid3.1159","doi":"https://doi.org/10.1002/iid3.1159","is_oa":true,"landing_page_url":"https://doi.org/10.1002/iid3.1159","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/iid3.1159","source":{"id":"https://openalex.org/S2764380340","display_name":"Immunity Inflammation and Disease","issn_l":"2050-4527","issn":["2050-4527"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunity, Inflammation and Disease","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/iid3.1159","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050717885","display_name":"Fawzi O. Ebrahim","orcid":"https://orcid.org/0000-0002-4420-8423","observed_orcids":["https://orcid.org/0000-0002-4420-8423"]},"institutions":[{"id":"https://openalex.org/I4405266545","display_name":"Libyan Biotechnology Research Center","ror":"https://ror.org/03qp6z628","country_code":"LY","type":"facility","lineage":["https://openalex.org/I4405266545","https://openalex.org/I4405286248"]}],"countries":["LY"],"is_corresponding":true,"raw_author_name":"Fawzi Ebrahim","raw_affiliation_strings":["Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya"],"raw_orcid":"https://orcid.org/0000-0002-4420-8423","affiliations":[{"raw_affiliation_string":"Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya","institution_ids":["https://openalex.org/I4405266545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007947848","display_name":"Asmaa Alboueishi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266545","display_name":"Libyan Biotechnology Research Center","ror":"https://ror.org/03qp6z628","country_code":"LY","type":"facility","lineage":["https://openalex.org/I4405266545","https://openalex.org/I4405286248"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Asma Alboueishi","raw_affiliation_strings":["Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya","institution_ids":["https://openalex.org/I4405266545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007920854","display_name":"Inas M. Alhudiri","orcid":"https://orcid.org/0000-0002-3371-0215","observed_orcids":["https://orcid.org/0000-0002-3371-0215"]},"institutions":[{"id":"https://openalex.org/I4405266545","display_name":"Libyan Biotechnology Research Center","ror":"https://ror.org/03qp6z628","country_code":"LY","type":"facility","lineage":["https://openalex.org/I4405266545","https://openalex.org/I4405286248"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Inas M. Alhudiri","raw_affiliation_strings":["Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya"],"raw_orcid":"https://orcid.org/0000-0002-3371-0215","affiliations":[{"raw_affiliation_string":"Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya","institution_ids":["https://openalex.org/I4405266545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040651828","display_name":"Salah Tabal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266545","display_name":"Libyan Biotechnology Research Center","ror":"https://ror.org/03qp6z628","country_code":"LY","type":"facility","lineage":["https://openalex.org/I4405266545","https://openalex.org/I4405286248"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Salah Al Tabal","raw_affiliation_strings":["Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya","institution_ids":["https://openalex.org/I4405266545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074713958","display_name":"Yosra Lamami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266545","display_name":"Libyan Biotechnology Research Center","ror":"https://ror.org/03qp6z628","country_code":"LY","type":"facility","lineage":["https://openalex.org/I4405266545","https://openalex.org/I4405286248"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Yosra Lamami","raw_affiliation_strings":["Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya","institution_ids":["https://openalex.org/I4405266545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031291712","display_name":"Samira M Al Dwigen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266545","display_name":"Libyan Biotechnology Research Center","ror":"https://ror.org/03qp6z628","country_code":"LY","type":"facility","lineage":["https://openalex.org/I4405266545","https://openalex.org/I4405286248"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Samira Al Dwigen","raw_affiliation_strings":["Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya","institution_ids":["https://openalex.org/I4405266545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093746766","display_name":"Sondos Ashleb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266545","display_name":"Libyan Biotechnology Research Center","ror":"https://ror.org/03qp6z628","country_code":"LY","type":"facility","lineage":["https://openalex.org/I4405266545","https://openalex.org/I4405286248"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Sondos Ashleb","raw_affiliation_strings":["Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya","institution_ids":["https://openalex.org/I4405266545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093746767","display_name":"Noha Ejenfawi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266545","display_name":"Libyan Biotechnology Research Center","ror":"https://ror.org/03qp6z628","country_code":"LY","type":"facility","lineage":["https://openalex.org/I4405266545","https://openalex.org/I4405286248"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Noha Ejenfawi","raw_affiliation_strings":["Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya","institution_ids":["https://openalex.org/I4405266545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014988393","display_name":"Mohamed B. Milad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266545","display_name":"Libyan Biotechnology Research Center","ror":"https://ror.org/03qp6z628","country_code":"LY","type":"facility","lineage":["https://openalex.org/I4405266545","https://openalex.org/I4405286248"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Mohamed B. Milad","raw_affiliation_strings":["Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya","institution_ids":["https://openalex.org/I4405266545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093746764","display_name":"Hayat Rhoumah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266545","display_name":"Libyan Biotechnology Research Center","ror":"https://ror.org/03qp6z628","country_code":"LY","type":"facility","lineage":["https://openalex.org/I4405266545","https://openalex.org/I4405286248"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Hayat Rhoumah","raw_affiliation_strings":["Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya","institution_ids":["https://openalex.org/I4405266545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027962277","display_name":"Salah Edin El Meshri","orcid":"https://orcid.org/0009-0006-8613-4625","observed_orcids":["https://orcid.org/0009-0006-8613-4625"]},"institutions":[{"id":"https://openalex.org/I4405266545","display_name":"Libyan Biotechnology Research Center","ror":"https://ror.org/03qp6z628","country_code":"LY","type":"facility","lineage":["https://openalex.org/I4405266545","https://openalex.org/I4405286248"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Salah Edin El Meshri","raw_affiliation_strings":["Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya"],"raw_orcid":"https://orcid.org/0009-0006-8613-4625","affiliations":[{"raw_affiliation_string":"Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya","institution_ids":["https://openalex.org/I4405266545"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071577730","display_name":"Adam I. Elzagheid","orcid":"https://orcid.org/0000-0002-7086-5937","observed_orcids":["https://orcid.org/0000-0002-7086-5937"]},"institutions":[{"id":"https://openalex.org/I4405266545","display_name":"Libyan Biotechnology Research Center","ror":"https://ror.org/03qp6z628","country_code":"LY","type":"facility","lineage":["https://openalex.org/I4405266545","https://openalex.org/I4405286248"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Adam Elzagheid","raw_affiliation_strings":["Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya"],"raw_orcid":"https://orcid.org/0000-0002-7086-5937","affiliations":[{"raw_affiliation_string":"Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya","institution_ids":["https://openalex.org/I4405266545"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5050717885"],"corresponding_institution_ids":["https://openalex.org/I4405266545"],"apc_list":{"value":3240,"currency":"USD","value_usd":3240},"apc_paid":{"value":3240,"currency":"USD","value_usd":3240},"fwci":0.6163,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.61760596,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"12","issue":"1","first_page":"e1159","last_page":"e1159"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13410","display_name":"Immune responses and vaccinations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chadox1-ncov-19-vaccine","display_name":"ChAdOx1 nCoV-19 vaccine","score":0.9459999799728394},{"id":"https://openalex.org/keywords/astrazeneca-oxford-vaccine","display_name":"AstraZeneca-Oxford vaccine","score":0.7540000081062317},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.8320000171661377},{"id":"https://openalex.org/keywords/covid-19-infection-history","display_name":"COVID-19 infection history","score":0.7599999904632568},{"id":"https://openalex.org/keywords/prior-infection","display_name":"prior infection","score":0.5770000219345093},{"id":"https://openalex.org/keywords/single-dose-vaccination","display_name":"single-dose vaccination","score":0.7680000066757202},{"id":"https://openalex.org/keywords/immune-booster","display_name":"immune booster","score":0.5440000295639038},{"id":"https://openalex.org/keywords/antibody-response","display_name":"antibody response","score":0.6420000195503235},{"id":"https://openalex.org/keywords/igg","display_name":"IgG","score":0.847000002861023},{"id":"https://openalex.org/keywords/spike-protein-antibodies","display_name":"spike protein antibodies","score":0.8240000009536743},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.8500000238418579},{"id":"https://openalex.org/keywords/serological-response","display_name":"serological response","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.7541124820709229},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.7361411452293396},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.6592453718185425},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6380621194839478},{"id":"https://openalex.org/C2778137277","wikidata":"https://www.wikidata.org/wiki/Q16532287","display_name":"Betacoronavirus","level":5,"score":0.5661342740058899},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5210368633270264},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5191870927810669},{"id":"https://openalex.org/C3020799909","wikidata":"https://www.wikidata.org/wiki/Q85438966","display_name":"Sars virus","level":5,"score":0.5111296772956848},{"id":"https://openalex.org/C2909376813","wikidata":"https://www.wikidata.org/wiki/Q57751738","display_name":"Coronavirus Infections","level":5,"score":0.44869473576545715},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4172726273536682},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36369967460632324},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.153845876455307},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1338028907775879},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.07547858357429504},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.0746431052684784}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000086663","descriptor_name":"COVID-19 Vaccines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000090985","descriptor_name":"ChAdOx1 nCoV-19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007109","descriptor_name":"Immunity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1002/iid3.1159","doi":"https://doi.org/10.1002/iid3.1159","is_oa":true,"landing_page_url":"https://doi.org/10.1002/iid3.1159","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/iid3.1159","source":{"id":"https://openalex.org/S2764380340","display_name":"Immunity Inflammation and Disease","issn_l":"2050-4527","issn":["2050-4527"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunity, Inflammation and Disease","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10797648","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10797648","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10797648/pdf/IID3-12-e1159.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immun Inflamm Dis","raw_type":"Text"},{"id":"pmid:38270312","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38270312","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunity, inflammation and disease","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:18c41cf582bf4c51a1628fed2c942d09","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/18c41cf582bf4c51a1628fed2c942d09","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Immunity, Inflammation and Disease, Vol 12, Iss 1, Pp n/a-n/a (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1002/iid3.1159","doi":"https://doi.org/10.1002/iid3.1159","is_oa":true,"landing_page_url":"https://doi.org/10.1002/iid3.1159","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/iid3.1159","source":{"id":"https://openalex.org/S2764380340","display_name":"Immunity Inflammation and Disease","issn_l":"2050-4527","issn":["2050-4527"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunity, Inflammation and Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4391027296.pdf","grobid_xml":"https://content.openalex.org/works/W4391027296.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W3036386821","https://openalex.org/W3042833857","https://openalex.org/W3081916995","https://openalex.org/W3131688063","https://openalex.org/W3131762051","https://openalex.org/W3135903766","https://openalex.org/W3136275452","https://openalex.org/W3144728481","https://openalex.org/W3160138987","https://openalex.org/W3167555428","https://openalex.org/W3179750870","https://openalex.org/W3189600091","https://openalex.org/W3191458817","https://openalex.org/W3192697308","https://openalex.org/W4200394452","https://openalex.org/W4221124875","https://openalex.org/W4310036617"],"related_works":["https://openalex.org/W4205167371","https://openalex.org/W4281651579","https://openalex.org/W4207019797","https://openalex.org/W3189600091","https://openalex.org/W3203505514","https://openalex.org/W4283753682","https://openalex.org/W3171800309","https://openalex.org/W3211699415","https://openalex.org/W4303513121","https://openalex.org/W4410110169"],"abstract_inverted_index":{"BACKGROUND:":[0],"Current":[1],"vaccines":[2,26,48],"against":[3],"COVID-19":[4,63,113,143,165,235],"effectively":[5],"reduce":[6],"morbidity":[7],"and":[8,10,21,65,91,109,129,180,193],"mortality":[9],"are":[11],"vitally":[12],"important":[13],"for":[14,275,280],"controlling":[15],"the":[16,59,118,126,135,219,252],"pandemic.":[17],"Between":[18],"December":[19],"2020":[20],"February":[22],"2021,":[23],"adenoviral":[24],"vector":[25],"such":[27],"as":[28,265],"ChAdOx1":[29,73,97,246,259],"(AstraZeneca-Oxford)":[30],"were":[31,85,167,174,184,201],"put":[32],"in":[33,49,158,171,177,203,224],"use.":[34],"Recent":[35],"reports":[36],"demonstrate":[37],"robust":[38],"serological":[39],"responses":[40,137],"to":[41,57,103],"a":[42,69,255,272,276],"single":[43,70,256],"dose":[44,71,95,257],"of":[45,72,96,112,121,138,147,152,164,242,258],"messenger":[46],"RNA":[47],"individuals":[50,83,139,148],"previously":[51,127,175,208,281],"infected":[52,128,209,282],"with":[53,140,145,218,239],"SARS-CoV-2.":[54],"We":[55,115,133],"aimed":[56],"study":[58,78],"association":[60],"between":[61,125,191],"previous":[62],"infection":[64,144,166,236,263],"antibody":[66,136,156,189,199],"levels":[67,120,157,190,200,241],"after":[68],"nCoV-19.":[74],"METHODS:":[75],"This":[76,270],"cross-sectional":[77],"was":[79,101,222],"conducted":[80],"on":[81,106],"657":[82],"who":[84,160,173,205],"either":[86],"convalescent":[87],"or":[88],"SARS-CoV-2":[89,243],"naive":[90],"had":[92,206],"received":[93],"one":[94],"(AstraZeneca).":[98],"A":[99],"questionnaire":[100],"used":[102],"collect":[104],"data":[105],"age,":[107],"sex,":[108],"self-reported":[110],"history":[111,163],"infection.":[114,153],"then":[116],"compared":[117,134,188,217],"average":[119],"immunoglobulin":[122],"G":[123],"(IgG)":[124],"COVID-19-naive":[130],"participants.":[131],"RESULTS:":[132],"confirmed":[141],"prior":[142,150],"those":[146,159,172,204],"without":[149],"evidence":[151],"The":[154],"mean":[155],"reported":[161],"no":[162],"substantially":[168],"lower":[169],"than":[170],"infected,":[176],"both":[178],"males":[179],"females.":[181],"Sex-related":[182],"differences":[183],"observed":[185,223],"when":[186],"we":[187],"men":[192],"women.":[194],"In":[195],"males,":[196],"anti-S":[197],"IgG":[198],"higher":[202,240],"been":[207],"(156.1":[210],"vs.":[211,227],"87.69":[212],"AU/mL,":[213,229],"p":[214,230],"=":[215,231],".009),":[216],"same":[220],"pattern":[221],"females":[225],"(113.5":[226],"90.69":[228],".005).":[232],"CONCLUSIONS:":[233],"Previous":[234],"is":[237],"associated":[238],"antibodies":[244],"following":[245],"(AstraZeneca)":[247],"vaccination.":[248],"Our":[249],"finding":[250],"supports":[251],"notion":[253],"that":[254],"nCoV-19":[260],"administered":[261],"post-SARS-CoV-2":[262],"serves":[264],"an":[266],"effective":[267],"immune":[268],"booster.":[269],"provides":[271],"possible":[273],"rationale":[274],"single-dose":[277],"vaccine":[278],"regimen":[279],"individuals.":[283]},"counts_by_year":[{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-01-20T00:00:00"}